Advertisement

Topics

Sosei eyes opportunity, takes back Japanese rights to dementia candidate

06:58 EST 9 Nov 2017 | thePharmaLetter

Tokyo’s Sosei and Dublin-headquartered Allergan are altering their $3 billion-plus collaboration, inked…

Original Article: Sosei eyes opportunity, takes back Japanese rights to dementia candidate

NEXT ARTICLE

More From BioPortfolio on "Sosei eyes opportunity, takes back Japanese rights to dementia candidate"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...